Real-world progression-free and overall survival of patients with metastatic colorectal cancer according to first and second-line treatment regimen: PROMETCO study
Find out more using the RESOURCES section
OCTOBER 2023
Overall and progression-free survival of patients with metastatic colorectal cancer: a real-world prospective, longitudinal cohort study on the continuum of care (PROMETCO)
Find out more using the RESOURCES section
September 2022
PROMETCO study: Metastatic colorectal cancer treatment patterns of the first 531 enrolled patients
Find out more using the DISCOVER and RESOURCES sections
January 2022
Baseline treatment patterns of the first 277 patients in PROMETCO: A real-world, prospective, longitudinal cohort study on the continuum of care in metastatic colorectal cancer
Find out more using the DISCOVER and RESOURCES sections
January 2022
Rationale and design of the PROMETCO study: A real-world, prospective, longitudinal cohort on the continuum of care of metastatic colorectal cancer from a clinical and patient perspective
Find out more using the DISCOVER and RESOURCES sections
June–July 2021
Patient baseline characteristics in the PROMETCO study: A real-world, prospective longitudinal cohort on the continuum of care of metastatic colorectal cancer
